29.9 C
New York
Thursday, September 3, 2026

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

148,415FansLike
396,312FollowersFollow
3,250SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x